Ingenion Medical Ltd. is a private medical device company that is developing a new generation of urinary catheters for both men & women, based upon a proprietary, patented platform technology that will significantly improve the patient experience, while also improving healthcare outcomes.
Currently, bladder management options available often lead to infection, poor quality of life, and increased healthcare costs. Ingenion’s latest innovation, ‘CymActive’ makes bladder management discreet, comfortable and safe.
Ingenion has a team of highly experienced individuals dedicated to delivering innovative patient care to the market. They have also received positive clinical and distributor feedback, and have multiple products in the pipeline.
Join us on 23 March at 6 pm as Edward Cappabianca, CEO of Ingenion talks more about Ingenion’s business, why they were formed, their growth plans, and where this round of investment will take them. Following the pitch, there will be an interactive Q&A session where you will have an opportunity to ask questions and delve deeper into the business.
Invest in advancing better bladder management solutions and improving lives with Ingenion. Because it’s now time for a change!
Click Here to register for the event.
For more information on Ingenion and to view the deal Click Here.
Note: You must be a self-certified investor to attend this event. *CAPITAL AT RISK
